Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Cells. 2020 May 9;9(5):1182. doi: 10.3390/cells9051182.
Chimeric antigen receptor (CAR)-T cells have demonstrated significant clinical potential; however, their strong antitumor activity may cause severe adverse effects. To ensure efficacy and safe CAR-T cell therapy, it is important to understand CAR's structure-activity relationship. To clarify the role of hinge and transmembrane domains in CAR and CAR-T cell function, we generated different chimeras and analyzed their expression levels and antigen-specific activity on CAR-T cells. First, we created a basic CAR with hinge, transmembrane, and signal transduction domains derived from CD3ζ, then we generated six CAR variants whose hinge or hinge/transmembrane domains originated from CD4, CD8α, and CD28. CAR expression level and stability on the T cell were greatly affected by transmembrane rather than hinge domain. Antigen-specific functions of most CAR-T cells depended on their CAR expression levels. However, CARs with a CD8α- or CD28-derived hinge domain showed significant differences in CAR-T cell function, despite their equal expression levels. These results suggest that CAR signaling intensity into T cells was affected not only by CAR expression level, but also by the hinge domain. Our discoveries indicate that the hinge domain regulates the CAR signaling threshold and the transmembrane domain regulates the amount of CAR signaling via control of CAR expression level.
嵌合抗原受体 (CAR)-T 细胞已显示出显著的临床潜力;然而,其强大的抗肿瘤活性可能会引起严重的不良反应。为了确保 CAR-T 细胞治疗的疗效和安全性,了解 CAR 的结构-活性关系非常重要。为了阐明铰链和跨膜结构域在 CAR 和 CAR-T 细胞功能中的作用,我们构建了不同的嵌合体,并分析了它们在 CAR-T 细胞上的表达水平和抗原特异性活性。首先,我们构建了一个基本的 CAR,其铰链、跨膜和信号转导结构域来源于 CD3ζ,然后我们构建了六个 CAR 变体,其铰链或铰链/跨膜结构域来源于 CD4、CD8α 和 CD28。跨膜结构域而非铰链结构域极大地影响了 T 细胞上 CAR 的表达水平和稳定性。大多数 CAR-T 细胞的抗原特异性功能取决于其 CAR 的表达水平。然而,源自 CD8α 或 CD28 的铰链域的 CAR 尽管表达水平相等,但在 CAR-T 细胞功能上表现出显著差异。这些结果表明,CAR 信号转导进入 T 细胞不仅受到 CAR 表达水平的影响,还受到铰链结构域的影响。我们的发现表明,铰链结构域调节 CAR 信号的阈值,而跨膜结构域通过控制 CAR 的表达水平来调节 CAR 信号的量。
J Immunother Cancer. 2024-10-4
J Hematol Oncol. 2017-3-13
Front Immunol. 2025-7-17
Front Immunol. 2025-7-18
Hum Vaccin Immunother. 2025-12
Int J Mol Sci. 2025-6-24
Int J Mol Sci. 2025-6-9
Cell Mol Immunol. 2025-6-6
Biochem Biophys Res Commun. 2020-6-25
Cancers (Basel). 2020-1-3
Mol Ther Oncolytics. 2019-8-28
Mol Ther Methods Clin Dev. 2018-12-31
N Engl J Med. 2018-7-5
N Engl J Med. 2018-2-1
JCI Insight. 2018-1-11